DOCS Stock Analysis: Buy, Sell, or Hold?
DOCS - Doximity, Inc.
$18.97
0.96 (5.33%)
β²
5d:
-26.98%
30d:
-21.77%
90d:
-24.18%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When DOCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called DOCS this week
75% bullish • 1 bearish
75% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: DOCS is down 27.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: DOCS is down 27.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.60
Based on 4.4% avg growth
INTRINSIC VALUE TODAY
$25.21
24.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DOCS is currently trading at $18.97, which is considered oversold relative to its 30-day fair value range of $21.74 to $25.71. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.7) compared to its historical average (20.2). Remarkably, the market is currently pricing in an annual earnings decline of 16.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $17.15, while resistance sits at $26.69. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.30 (+43.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $17.15, while resistance sits at $26.69. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.30 (+43.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$21.74 -
$25.71
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 43.9% below Wall St target ($27.30)
- WARNING: Recommendation downgraded due to -27.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$21.74 -
$25.71
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$17.15
Resistance Level
$26.69
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.70
Wall Street Target
$27.30
(+43.9%)
Revenue Growth (YoY)
5.1%
Earnings Growth (YoY)
-67.7%
Profit Margin
30.4%
Valuation Discount vs History
-16.6% cheaper
PE vs Historical
11.7 vs 20.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.6%
(market-implied from PE analysis)
1-Year Target
$17.07
(-10%)
2-Year Target
$15.37
(-19%)
3-Year Target
$13.83
(-27%)
3-Yr Target (if PE normalizes)
(PE: 12β20)
$23.87
(+26%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 4.8%)
$41.16
(+117%)
Base:
(SPY PE: 11.7, Growth: 4.8%)
$21.83
(+15%)
Bear:
(PE: 9.9, Growth: 4.8%)
$18.55
(-2%)
π
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 19.96 | Current EPS (TTM): $0.98
Bull Case
$35.58
(+88%)
Analyst growth 65.4%, PE expands to 22.0
Base Case
$32.35
(+71%)
Market implied 65.4%, PE stable at 20.0
Bear Case
$13.30
(-30%)
Severe decline -20.0%, PE contracts to 17.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.7 to 20.2
Stabilization Target:
$32.74
(+72.6%)
PE Expansion Potential:
+72.6%
Share & Embed Analysis
Last updated: May 15, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
Data refreshes hourly during market hours. Next update: 11:42 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DOCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Siddharth Sitaram
SELL
2427 shares
2026-04-10
Siddharth Sitaram
SELL
2319 shares
2026-03-10
Kira Scherer Wampler
SELL
2000 shares
2026-03-03
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 55 HOLD |
|
GEHC
GE HealthCare Technologi⦠|
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$16 | 52 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$5 | 60 HOLD |